Company

TTY Biopharm Company Ltd

Headquarters: Taipei, Taiwan

TWSE: 4105 +0.54%

Market Cap

TW$19.10 Billion

TWD as of July 1, 2024

US$586.5 Million

Market Cap History

TTY Biopharm Company Ltd market capitalization over time

Evolution of TTY Biopharm Company Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of TTY Biopharm Company Ltd

Detailed Description

TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, Europe, and internationally. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, and Yondelis names for anti-cancer and supplementary treatments. The company also provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. The company was founded in 1960 and is headquartered in Taipei, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

TTY Biopharm Company Ltd has the following listings and related stock indices.


Stock: TWSE: 4105 wb_incandescent

Details

Headquarters:

No.3-1, Park Street

3rd Floor Nangang District

Taipei, 11503

Taiwan

Phone: 886 2 2652 5999